[go: up one dir, main page]

WO2005113537B1 - Urees antagonistes vis-a-vis du recepteur p2y1 utiles dans le traitement des etats thrombotiques - Google Patents

Urees antagonistes vis-a-vis du recepteur p2y1 utiles dans le traitement des etats thrombotiques

Info

Publication number
WO2005113537B1
WO2005113537B1 PCT/US2005/016525 US2005016525W WO2005113537B1 WO 2005113537 B1 WO2005113537 B1 WO 2005113537B1 US 2005016525 W US2005016525 W US 2005016525W WO 2005113537 B1 WO2005113537 B1 WO 2005113537B1
Authority
WO
WIPO (PCT)
Prior art keywords
substituted
alkyl
occurrence
carbon atoms
heterocycle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/016525
Other languages
English (en)
Other versions
WO2005113537A2 (fr
WO2005113537A3 (fr
Filing date
Publication date
Priority claimed from US11/126,567 external-priority patent/US7550499B2/en
Priority to HR20090468T priority Critical patent/HRP20090468T1/hr
Priority to DK05779448T priority patent/DK1750704T3/da
Priority to JP2007513323A priority patent/JP4795336B2/ja
Priority to DE602005015577T priority patent/DE602005015577D1/de
Priority to CN2005800231306A priority patent/CN1984655B/zh
Priority to EP05779448A priority patent/EP1750704B1/fr
Application filed filed Critical
Priority to MXPA06013024A priority patent/MXPA06013024A/es
Priority to PL05779448T priority patent/PL1750704T3/pl
Priority to AU2005245400A priority patent/AU2005245400A1/en
Priority to CNA2005800236206A priority patent/CN1984892A/zh
Publication of WO2005113537A2 publication Critical patent/WO2005113537A2/fr
Publication of WO2005113537A3 publication Critical patent/WO2005113537A3/fr
Publication of WO2005113537B1 publication Critical patent/WO2005113537B1/fr
Anticipated expiration legal-status Critical
Priority to NO20065544A priority patent/NO20065544L/no
Priority to CY20091101048T priority patent/CY1109487T1/el
Ceased legal-status Critical Current

Links

Abstract

L'invention concerne des urées qui renferment des hétérocycles à substitution N-aryle ou N-hétéroaryle et leurs analogues, qui sont des inhibiteurs sélectifs du récepteur humain P2Y1. L'invention concerne également diverses compositions pharmaceutiques renfermant ces urées, et des procédés de traitement de maladies réagissant à la modulation de l'activité du récepteur en question.
PCT/US2005/016525 2004-05-12 2005-05-11 Urees antagonistes vis-a-vis du recepteur p2y1 utiles dans le traitement des etats thrombotiques Ceased WO2005113537A2 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
PL05779448T PL1750704T3 (pl) 2004-05-12 2005-05-11 Pochodne mocznika jako antagoniści receptora P2Y1 użyteczne w leczeniu stanów zakrzepowych
MXPA06013024A MXPA06013024A (es) 2004-05-12 2005-05-11 Antagonistas de urea del receptor p2y1 util en el tratamiento de condiciones tromboticas.
DK05779448T DK1750704T3 (da) 2004-05-12 2005-05-11 Urinstof-antagonister af P2Y1-receptorer, der er anvendelige i behandlingen af trombotiske tilstande
JP2007513323A JP4795336B2 (ja) 2004-05-12 2005-05-11 血栓症病態の治療に有用なｐ２ｙ１レセプターのウレアアンタゴニスト
DE602005015577T DE602005015577D1 (de) 2004-05-12 2005-05-11 Harnstoff-antagonisten des p2y1-rezeptors zur behandlung von thromboseleiden
CN2005800231306A CN1984655B (zh) 2004-05-12 2005-05-11 可用于治疗血栓形成性疾病的p2y1受体脲拮抗剂
EP05779448A EP1750704B1 (fr) 2004-05-12 2005-05-11 Urees antagonistes vis-a-vis du recepteur p2y1 utiles dans le traitement des etats thrombotiques
HR20090468T HRP20090468T1 (hr) 2004-05-12 2005-05-11 Urea antagonisti p2y1 receptora korisni u liječenju trombotičkih stanja
CNA2005800236206A CN1984892A (zh) 2004-05-12 2005-05-11 用于治疗血栓性疾病的p2y1受体的脲拮抗剂
AU2005245400A AU2005245400A1 (en) 2004-05-12 2005-05-11 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
NO20065544A NO20065544L (no) 2004-05-12 2006-12-01 Urea-antagonister av P2Y1-reseptor anvendbare i behandling av trombotiske tilstander.
CY20091101048T CY1109487T1 (el) 2004-05-12 2009-10-13 Ανταγωνιστες τυπου ουριας του υποδοχεα p2y1 χρησιμοι στην αγωγη θρομβωτικων καταστασεων

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US57028804P 2004-05-12 2004-05-12
US60/570,288 2004-05-12
US66573505P 2005-03-28 2005-03-28
US60/665,735 2005-03-28
US11/126,567 2005-05-10
US11/126,567 US7550499B2 (en) 2004-05-12 2005-05-10 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions

Publications (3)

Publication Number Publication Date
WO2005113537A2 WO2005113537A2 (fr) 2005-12-01
WO2005113537A3 WO2005113537A3 (fr) 2005-12-22
WO2005113537B1 true WO2005113537B1 (fr) 2006-02-16

Family

ID=35169638

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/016525 Ceased WO2005113537A2 (fr) 2004-05-12 2005-05-11 Urees antagonistes vis-a-vis du recepteur p2y1 utiles dans le traitement des etats thrombotiques

Country Status (17)

Country Link
US (1) US7550499B2 (fr)
EP (1) EP1750704B1 (fr)
JP (1) JP4795336B2 (fr)
KR (1) KR20070011479A (fr)
CN (2) CN1984892A (fr)
AU (1) AU2005245400A1 (fr)
CY (1) CY1109487T1 (fr)
DE (1) DE602005015577D1 (fr)
DK (1) DK1750704T3 (fr)
ES (1) ES2328716T3 (fr)
HR (1) HRP20090468T1 (fr)
MX (1) MXPA06013024A (fr)
NO (1) NO20065544L (fr)
PL (1) PL1750704T3 (fr)
PT (1) PT1750704E (fr)
SI (1) SI1750704T1 (fr)
WO (1) WO2005113537A2 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7470712B2 (en) * 2004-01-21 2008-12-30 Bristol-Myers Squibb Company Amino-benzazoles as P2Y1 receptor inhibitors
AU2005245389A1 (en) 2004-05-12 2005-12-01 Bristol-Myers Squibb Company Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
US7645778B2 (en) 2005-01-19 2010-01-12 Bristol-Myers Squibb Company Heteroaryl compounds as P2Y1 receptor inhibitors
DE602006021306D1 (fr) 2005-06-27 2011-05-26 Bristol Myers Squibb Co
ATE485269T1 (de) * 2005-06-27 2010-11-15 Bristol Myers Squibb Co C-verknüpfte zyklische antagonisten des p2y1- rezeptors mit eignung bei der behandlung thrombotischer leiden
WO2007002634A1 (fr) * 2005-06-27 2007-01-04 Bristol-Myers Squibb Company Antagonistes carbocycliques et heherocycliques du recepteur p2y1, utiles pour traiter des etats pathologiques thrombotiques
WO2007002584A1 (fr) * 2005-06-27 2007-01-04 Bristol-Myers Squibb Company Mimetiques lineaires de l’uree antagonistes du recepteur p2y1, utilises dans le traitement des troubles thrombotiques
WO2008023235A1 (fr) * 2006-08-25 2008-02-28 Pfizer Products Inc. Dérivés de pyrazole en tant qu'agents antiagrégants plaquettaires et antithrombotiques
US7960569B2 (en) 2006-10-17 2011-06-14 Bristol-Myers Squibb Company Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
KR100858460B1 (ko) * 2007-05-16 2008-09-12 최원진 장아찌의 제조방법
US8912184B1 (en) 2010-03-01 2014-12-16 Alzheimer's Institute Of America, Inc. Therapeutic and diagnostic methods
NZ601788A (en) * 2010-03-01 2014-11-28 Myrexis Inc Inhibitors of nicotinamide phosphoribosyltransferase and therapeutic uses thereof
EA201490152A1 (ru) 2011-06-24 2014-05-30 Эмджен Инк. Антагонисты trpm8 и их применение при лечении
JP2014517074A (ja) 2011-06-24 2014-07-17 アムジエン・インコーポレーテツド Ｔｒｐｍ８アンタゴニストおよび治療におけるそれらの使用
WO2013017678A1 (fr) 2011-08-04 2013-02-07 Intervet International B.V. Nouveaux composés de spiroindoline
CN103172543B (zh) * 2011-12-21 2016-02-10 中国科学院上海药物研究所 一种脲类化合物、制备方法及其用途
WO2014022349A1 (fr) * 2012-08-01 2014-02-06 Bristol-Myers Squibb Company Antagonistes de 7-hydroxy-spiropipipéridine indolinyle du récepteur p2y1
WO2014022343A1 (fr) * 2012-08-01 2014-02-06 Bristol-Myers Squibb Company Antagonistes de 7-hydroxy-indolinyle du récepteur p2y1
EP2880034B1 (fr) 2012-08-01 2016-06-22 Bristol-Myers Squibb Company Antagonistes d'amino-hétéroaryle 7-hydroxyspiropipéridine indolinyle du récepteur p2y1
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
CN102924442B (zh) * 2012-11-15 2014-10-29 沈阳药科大学 含有噻唑环的色满类化合物及其类似物和医药用途
CN103012381B (zh) * 2013-01-10 2015-01-07 山东大学 苯基呋喃类化合物、其制备方法及在制备抗心律失常药物中的应用
CN104402875A (zh) * 2014-12-25 2015-03-11 西安山川医药科技有限公司 N-(2-氨基乙基)-n′-(6-取代-2-苯并噻唑基)脲及其盐类化合物的合成方法和用途
GB201721957D0 (en) * 2017-12-27 2018-02-07 Bp Oil Int Methods for preparing fuel additives
GB201721964D0 (en) 2017-12-27 2018-02-07 Bp Oil Int Methods for preparing fuel additives
GB201721960D0 (en) 2017-12-27 2018-02-07 Bp Oil Int Methods for preparing fuel additives
GB201721961D0 (en) 2017-12-27 2018-02-07 Bp Oil Int Methods for preparing fuel additives
GB201721967D0 (en) 2017-12-27 2018-02-07 Bp Oil Int Methods for preparing fuel additives
CN110305141B (zh) * 2019-07-18 2022-01-11 深圳市三启药物开发有限公司 一种螺(3,3’-异丙基吡咯烷氧化吲哚)类肝x受体调节剂及其制备方法和应用
CN114853684A (zh) * 2021-02-03 2022-08-05 北京万全德众医药生物技术有限公司 一种卢美派隆中间体的纯化方法
EP4095134A1 (fr) 2021-05-25 2022-11-30 UCL Business Ltd Composés polycycliques pour le traitement de troubles neurologiques
EP4094762A1 (fr) 2021-05-25 2022-11-30 UCL Business Ltd Traitement de troubles neurologiques

Family Cites Families (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3118888A (en) 1964-01-21 Acylated s-triazines and process for their preparation
NL280954A (fr) 1961-07-14
US4179563A (en) 1978-05-19 1979-12-18 Warner-Lambert Company 3-Aryloxy-substituted-aminopyridines and methods for their production
US4186199A (en) 1978-11-02 1980-01-29 American Hoechst Corporation Indolo-,1,2-dihydroindolo-, and 1,2,6,7-tetrahydroindolo [1,7-ab][1,5] benzodiazepines
DE3065190D1 (en) 1979-11-05 1983-11-10 Beecham Group Plc Enzyme derivatives, and their preparation
JPS56166180A (en) 1980-05-28 1981-12-21 Chugai Pharmaceut Co Ltd Dibenzoxazepine derivative and its preparation
JPS56167649A (en) 1980-05-30 1981-12-23 Chugai Pharmaceut Co Ltd Diphenyl ether derivative
JPS5872562A (ja) * 1981-10-23 1983-04-30 Mitsubishi Chem Ind Ltd テトラヒドロフタルイミド類
US4663453A (en) 1983-05-18 1987-05-05 Hoechst-Roussel Pharmaceuticals Inc. Benzo[b]pyrrolo[3,2,1-jk][1,4]benzodiazepines having dopamine receptor activity
US4761411A (en) 1983-05-18 1988-08-02 Hoechst-Roussel Pharmaceuticals Inc. Dihydrobenzopyrrolobenzodiazepines useful for treating pyschoses
JPS62280847A (ja) 1986-05-30 1987-12-05 Konica Corp 新規なマゼンタカプラ−を含有するハロゲン化銀写真感光材料
US4840947A (en) 1986-10-14 1989-06-20 Hoechst-Roussel Pharmaceuticals, Inc. Antiinflammatory and analgesic piperidin-4-yl-tetracyclic benzodiazepines and use thereas
JP2577222B2 (ja) 1987-04-10 1997-01-29 興和株式会社 新規な置換アニリド誘導体
JPH0339740A (ja) 1989-07-06 1991-02-20 Konica Corp 転写型熱現像カラー感光材料
JP2951434B2 (ja) 1991-04-18 1999-09-20 三菱製紙株式会社 電子写真感光体
NZ264063A (en) 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
JP3395285B2 (ja) 1993-10-06 2003-04-07 日本製紙株式会社 感熱記録体
US5547966A (en) 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
US5612359A (en) 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
DE4443641A1 (de) 1994-12-08 1996-06-13 Bayer Ag Substituierte Carbonsäureamide
EP0809492A4 (fr) 1995-02-17 2007-01-24 Smithkline Beecham Corp Antagonistes des recepteurs d'il-8
PL322843A1 (en) 1995-03-20 1998-02-16 Lilly Co Eli 5-substituted 3-91,2,3,6-tetrahydropyridin-4-yl)- and 3-9piperydin-4-4-yl0-1h-indoles nevel 5-htif natagonists
AU7340096A (en) 1995-11-07 1997-05-29 Kirin Beer Kabushiki Kaisha Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same
CZ298098A3 (cs) 1996-03-25 1999-02-17 Eli Lilly And Company Tetrahydro-beta-karbolinové sloučeniny
CA2241687A1 (fr) 1996-10-30 1998-05-07 Kenneth A. Jacobson Antagonistes des recepteurs p2y
US6020357A (en) 1996-12-23 2000-02-01 Dupont Pharmaceuticals Company Nitrogen containing heteroaromatics as factor Xa inhibitors
US6187797B1 (en) 1996-12-23 2001-02-13 Dupont Pharmaceuticals Company Phenyl-isoxazoles as factor XA Inhibitors
TW536540B (en) 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
US5858289A (en) 1997-02-24 1999-01-12 Global Consulting, Inc. Process for preparing compressed shape of ceramic fiber
ZA985247B (en) 1997-06-19 1999-12-17 Du Pont Merck Pharma Guanidine mimics as factor Xa inhibitors.
AR016817A1 (es) * 1997-08-14 2001-08-01 Smithkline Beecham Plc Derivados de fenilurea o feniltiourea, procedimiento para su preparacion, coleccion de compuestos, compuestos intermediarios, composicion farmaceutica,metodo de tratamiento y uso de dichos compuestos para la manufactura de un medicamento
WO2000077027A2 (fr) 1999-06-14 2000-12-21 Tularik Limited Composes
RU2212407C2 (ru) 1997-11-10 2003-09-20 Бристол-Маерс Сквибб Компани Бензотиазольные ингибиторы протеинтирозинкиназ
EP1047691A1 (fr) 1997-12-12 2000-11-02 Smithkline Beecham Plc Derives de quinoleinepiperazine et de quinoleinepiperidine, leur preparation et leur utilisation en tant qu'antagonistes combines des recepteurs 5-ht1a, 5-ht1b et 5-ht1d
DK1042305T3 (da) 1997-12-22 2005-09-19 Bayer Pharmaceuticals Corp Inhibering af p38-kinase ved anvendelse af symmetriske og asymmetriske diphenylurinstoffer
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
CA2318199A1 (fr) * 1998-01-15 1999-07-22 Cor Therapeutics, Inc. Inhibiteurs des recepteurs d'adp des plaquettes
US6329395B1 (en) 1998-06-08 2001-12-11 Schering Corporation Neuropeptide Y5 receptor antagonists
DK1094816T3 (da) 1998-07-06 2009-04-06 Bristol Myers Squibb Co Biphenylsulfonamider som dobbelte angiotensin-endothelin-receptorantagonister
ATE287875T1 (de) 1998-10-06 2005-02-15 Dainippon Pharmaceutical Co 2,3-disubstituierte pyridinderivate, verfahren zur derren herstellung, sie enthaltende wirkstoffzubereitungen und zwischenprodukte für die herstellung
ATE290524T1 (de) 1998-10-20 2005-03-15 Takeda Pharmaceutical Aromatische aminderivate, verfahren zu ihrer herstellung und mittel, die diese enthalten
GB9823873D0 (en) 1998-10-30 1998-12-30 Pharmacia & Upjohn Spa 2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
HUP0202248A3 (en) 1999-03-12 2006-06-28 Boehringer Ingelheim Pharma Compounds useful as anti-inflammatory agents
US6548529B1 (en) 1999-04-05 2003-04-15 Bristol-Myers Squibb Company Heterocyclic containing biphenyl aP2 inhibitors and method
HUP0202708A3 (en) 1999-04-15 2004-12-28 Bristol Myers Squibb Co Cyclic protein tyrosine kinase inhibitors, pharmaceutical compositions containing them and their use
CO5200760A1 (es) 1999-06-16 2002-09-27 Smithkline Beecham Corp Antagonistas del receptor de la il-8 ceptor il-8
JP2001089412A (ja) 1999-09-22 2001-04-03 Otsuka Pharmaceut Co Ltd ベンゼン誘導体またはその医薬的に許容される塩
WO2001023358A1 (fr) 1999-09-27 2001-04-05 Sagami Chemical Research Center Derives pyrazole, intermediaires pour la preparation de ces derives, procedes de preparation des derives et intermediaires, et herbicides dont ces derives sont le principe actif
MY125533A (en) 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
ATE336492T1 (de) 2000-01-14 2006-09-15 Us Gov Health & Human Serv Methonocarbacycloalkylanaloga von nucleosiden
WO2001055146A1 (fr) 2000-01-29 2001-08-02 Lg Chem Investment Ltd. INHIBITEURS DU FACTEUR Xa CONTENANT DES ARYLAMIDINES ET DES DERIVES, ET PROMEDICAMENTS OBTENUS A PARTIR DESDITS INHIBITEURS
US6906063B2 (en) 2000-02-04 2005-06-14 Portola Pharmaceuticals, Inc. Platelet ADP receptor inhibitors
DE60114994T2 (de) * 2000-02-04 2006-08-03 Portola Pharmaceuticals, Inc., South San Francisco Blutplättchen-adp-rezeptor-inhibitoren
SK12712002A3 (sk) 2000-02-07 2003-02-04 Abbott Gmbh & Co. Kg Deriváty 2-benzotiazolylmočoviny a ich použitie ako inhibítorov proteínkináz
WO2001072751A1 (fr) 2000-03-29 2001-10-04 Knoll Gesellschaft Mit Beschraenkter Haftung Pyrrolopyrimidines utilisees comme inhibiteurs de tyrosine kinases
WO2001074793A2 (fr) 2000-04-03 2001-10-11 3-Dimensional Pharmaceuticals, Inc. Thiazoles substitues et utilisation associee en tant qu'inhibiteurs de l'inhibiteur-1 d'activateur de plasminogene
AR035216A1 (es) 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
JP2004517936A (ja) 2001-01-31 2004-06-17 ピーアンドジー−クレイロール・インコーポレイテッド 酸化毛髪染色において使用する新規のカップラー
WO2002064211A1 (fr) 2001-02-09 2002-08-22 Merck & Co., Inc. Inhibiteurs de thrombine
US6706711B2 (en) 2001-04-27 2004-03-16 Vertex Pharmaceuticals Incorporated Pyrazole derived kinase inhibitor
IL158783A0 (en) 2001-05-08 2004-05-12 Schering Ag Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
AU2002317377A1 (en) 2001-07-20 2003-03-03 Cancer Research Technology Limited Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer
JP2005501873A (ja) 2001-07-31 2005-01-20 バイエル・ヘルスケア・アクチェンゲゼルシャフト アミン誘導体
WO2003013517A1 (fr) 2001-08-06 2003-02-20 Pharmacia Italia S.P.A. Dérivés d'aminoisoxazole agissant comme inhibiteurs de la kinase
CN102617567A (zh) 2001-09-21 2012-08-01 百时美施贵宝公司 含有内酰胺的化合物及其衍生物作为Xa因子的抑制剂
WO2003045920A1 (fr) 2001-11-27 2003-06-05 Merck & Co., Inc. Composes 4-aminoquinoleines
US20050154230A1 (en) 2001-12-26 2005-07-14 Bayer Healthcare Ag Urea derivatives
JP2003192587A (ja) 2001-12-26 2003-07-09 Bayer Ag 尿素誘導体
AU2003210969A1 (en) 2002-02-11 2003-09-04 Bayer Corporation Aryl ureas with raf kinase and angiogenesis inhibiting activity
AU2003209116A1 (en) 2002-02-11 2003-09-04 Bayer Pharmaceuticals Corporation Aryl ureas with angiogenesis inhibiting activity
AU2003209119A1 (en) 2002-02-11 2003-09-04 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
DE10213228A1 (de) 2002-03-25 2003-10-16 Bayer Ag Cyclopenten-Derivate
CN1665808A (zh) 2002-05-06 2005-09-07 沃泰克斯药物股份有限公司 噻二唑或噁二唑及其作为jak蛋白激酶抑制剂的用途
CA2488642C (fr) 2002-06-27 2011-09-06 Dharma Rao Polisetti Derives d'arylcarbonyle servant d'activateurs de glucokinase
US20060058395A1 (en) 2002-08-01 2006-03-16 Neurosearch A/S Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
DE60328202D1 (de) 2002-09-05 2009-08-13 Neurosearch As Diarylharnstoffderivate und deren verwendung als chloridkanalblocker
EP1402888A1 (fr) 2002-09-18 2004-03-31 Jerini AG Utilisation des composés carbocycliques substitués comme inhibiteurs de Rotamases
US20040209930A1 (en) 2002-10-02 2004-10-21 Carboni Joan M. Synergistic methods and compositions for treating cancer
EP1565429B1 (fr) 2002-11-21 2009-05-13 Neurosearch A/S Derives de ureido diaryle et leur utilisation medicale
US7056889B2 (en) 2002-12-16 2006-06-06 Kimberly-Clark, Worldwide, Inc. Compounds that bind P2Y2 or P2Y1 receptors
WO2004085433A2 (fr) 2003-03-28 2004-10-07 Pharmacia & Upjohn Company Llc Modulateurs allosteriques positifs du recepteur nicotinique de l'acetylcholine
US7247654B2 (en) 2003-06-04 2007-07-24 Bristol-Myers Squibb Company 3,4-disubstituted benzamidines and benzylamines, and analogues thereof, useful as serine protease inhibitors
TWM252710U (en) 2003-07-18 2004-12-11 Huei-Chiun Shiu Annealing equipment
EP1661879A4 (fr) 2003-08-04 2006-11-29 Ono Pharmaceutical Co Compose d'ether de diphenyle, sa methode de preparation et d'utilisation
AU2004266228A1 (en) 2003-08-13 2005-03-03 Amgen, Inc. Melanin concentrating hormone receptor antagonists
CA2541751A1 (fr) 2003-10-14 2005-04-28 Eli Lilly And Company Derives de phenoxyether utilise comme modulateurs de recepteur ppar
PE20050444A1 (es) 2003-10-31 2005-08-09 Takeda Pharmaceutical Compuestos de piridina como inhibidores de la peptidasa
ES2711313T3 (es) 2003-12-26 2019-05-03 Masatoshi Hagiwara Método de regulación de la fosforilación de la proteína SR y agentes antivirales que comprenden el regulador de la actividad de la proteína SR como ingrediente activo
US7470712B2 (en) 2004-01-21 2008-12-30 Bristol-Myers Squibb Company Amino-benzazoles as P2Y1 receptor inhibitors
TW200530236A (en) * 2004-02-23 2005-09-16 Chugai Pharmaceutical Co Ltd Heteroaryl phenylurea
AU2005245389A1 (en) 2004-05-12 2005-12-01 Bristol-Myers Squibb Company Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
US7645778B2 (en) 2005-01-19 2010-01-12 Bristol-Myers Squibb Company Heteroaryl compounds as P2Y1 receptor inhibitors
CA2598993C (fr) 2005-02-25 2013-09-03 Serenex, Inc. Derives de tetrahydroindolone et de tetrahydroindazolone
DE602006021306D1 (fr) 2005-06-27 2011-05-26 Bristol Myers Squibb Co
WO2007002584A1 (fr) 2005-06-27 2007-01-04 Bristol-Myers Squibb Company Mimetiques lineaires de l’uree antagonistes du recepteur p2y1, utilises dans le traitement des troubles thrombotiques
ATE485269T1 (de) 2005-06-27 2010-11-15 Bristol Myers Squibb Co C-verknüpfte zyklische antagonisten des p2y1- rezeptors mit eignung bei der behandlung thrombotischer leiden
WO2007002634A1 (fr) 2005-06-27 2007-01-04 Bristol-Myers Squibb Company Antagonistes carbocycliques et heherocycliques du recepteur p2y1, utiles pour traiter des etats pathologiques thrombotiques

Similar Documents

Publication Publication Date Title
WO2005113537B1 (fr) Urees antagonistes vis-a-vis du recepteur p2y1 utiles dans le traitement des etats thrombotiques
RU2399620C2 (ru) Производные хинуклидина и их применение в качестве антагонистов мускариновых рецепторов м3
ES2858314T3 (es) Procedimiento para compuesto antifúngico
JP2002030084A5 (fr)
WO2007002635B1 (fr) Antagonistes cycliques a liaison c du recepteur p2y1, utiles pour traiter des etats pathologiques thrombotiques
JP2002536329A5 (fr)
JP2006524222A5 (fr)
JP2009537461A5 (fr)
JP2006505543A5 (fr)
JP2005539088A5 (fr)
JP2006504658A5 (fr)
US8877787B2 (en) EP4 agonist
JP2005504042A5 (fr)
WO2006078621B1 (fr) Composes heteroaryle tenant lieu d'inhibiteurs du recepteur p2y1
AU2015231234A1 (en) Antifungal compound process
JP2007520440A5 (fr)
JP2003502367A5 (fr)
JP2008545718A5 (fr)
JP2003507380A5 (fr)
JP2007538031A5 (fr)
KR100785675B1 (ko) 칼슘 수용체 길항약
JP2009503110A5 (fr)
RU2000101307A (ru) Халконы, обладающие антипролиферативной активностью
TWI555744B (zh) Novel EP4 agonists
WO1997049388A1 (fr) Medicaments contre des maladies renales et agents de preservation d'organes